Ersilia Lucenteforte

8.5k total citations · 1 hit paper
144 papers, 4.4k citations indexed

About

Ersilia Lucenteforte is a scholar working on Surgery, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Ersilia Lucenteforte has authored 144 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Surgery, 23 papers in Epidemiology and 22 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Ersilia Lucenteforte's work include Glaucoma and retinal disorders (11 papers), Retinal Diseases and Treatments (11 papers) and Retinal Imaging and Analysis (9 papers). Ersilia Lucenteforte is often cited by papers focused on Glaucoma and retinal disorders (11 papers), Retinal Diseases and Treatments (11 papers) and Retinal Imaging and Analysis (9 papers). Ersilia Lucenteforte collaborates with scholars based in Italy, United Kingdom and France. Ersilia Lucenteforte's co-authors include Carlo La Vecchia, Eva Negri, Silvia Deandrea, Francesca Bravi, Roberto Foschi, Gianni Virgili, Mariacristina Parravano, Cristina Bosetti, Iris Gordon and Jennifer Evans and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Ersilia Lucenteforte

132 papers receiving 4.3k citations

Hit Papers

Risk Factors for Falls in Community-dwelling Older People 2010 2026 2015 2020 2010 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ersilia Lucenteforte Italy 31 1.0k 796 707 695 647 144 4.4k
Alan J. Sinclair United Kingdom 49 398 0.4× 967 1.2× 127 0.2× 1.6k 2.4× 82 0.1× 204 9.3k
Nathalie de Rekeneire United States 41 670 0.7× 655 0.8× 106 0.1× 978 1.4× 37 0.1× 78 7.0k
Ronald G. Marks United States 35 77 0.1× 190 0.2× 846 1.2× 399 0.6× 400 0.6× 113 4.1k
Jing Tian United States 32 44 0.0× 196 0.2× 758 1.1× 554 0.8× 789 1.2× 152 5.3k
Francesca Bravi Italy 40 1.0k 1.0× 730 0.9× 131 0.2× 993 1.4× 12 0.0× 102 5.5k
Alphons G.H. Kessels Netherlands 24 98 0.1× 355 0.4× 450 0.6× 467 0.7× 37 0.1× 51 4.3k
Suzanne Satterfield United States 27 447 0.4× 417 0.5× 81 0.1× 595 0.9× 21 0.0× 37 4.1k
Satoru Kodama Japan 35 84 0.1× 157 0.2× 180 0.3× 1.1k 1.6× 76 0.1× 226 7.5k
Tomasz Grodzicki Poland 34 70 0.1× 192 0.2× 174 0.2× 513 0.7× 42 0.1× 354 4.9k
Koji Yonemoto Japan 41 24 0.0× 363 0.5× 343 0.5× 1.1k 1.6× 296 0.5× 110 5.1k

Countries citing papers authored by Ersilia Lucenteforte

Since Specialization
Citations

This map shows the geographic impact of Ersilia Lucenteforte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ersilia Lucenteforte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ersilia Lucenteforte more than expected).

Fields of papers citing papers by Ersilia Lucenteforte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ersilia Lucenteforte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ersilia Lucenteforte. The network helps show where Ersilia Lucenteforte may publish in the future.

Co-authorship network of co-authors of Ersilia Lucenteforte

This figure shows the co-authorship network connecting the top 25 collaborators of Ersilia Lucenteforte. A scholar is included among the top collaborators of Ersilia Lucenteforte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ersilia Lucenteforte. Ersilia Lucenteforte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Orlandi, Marco, Stefano Masi, Ersilia Lucenteforte, et al.. (2025). Periodontitis treatment and progression of carotid intima-media thickness: a randomized trial. European Heart Journal. 2 indexed citations
2.
Ceccarelli, Luca, Sarah A. Mazzilli, Davide Petri, et al.. (2024). Evaluating hepatitis C cascade of care surveillance system in Tuscany, Italy, through a population retrospective data-linkage study, 2015–2021. BMC Infectious Diseases. 24(1). 362–362.
3.
Lucenteforte, Ersilia, Maria Cristina Mondardini, Fabrizio Chiusolo, et al.. (2024). What Italian PICU Healthcare Providers Think About Donation After Cardiocirculatory Determination of Death: A National Survey. Pediatric Transplantation. 28(5). e14806–e14806. 1 indexed citations
4.
Bellini, Arianna, Maurizio Nordio, Eliana Ferroni, et al.. (2024). Effectiveness and safety of immunosuppressive regimens used as maintenance therapy in kidney transplantation: The CESIT study. PLoS ONE. 19(1). e0295205–e0295205. 2 indexed citations
5.
D’Alessandro, Claudia, Domenico Giannese, Mary Ruisi, et al.. (2024). Nutrition and Physical Activity in Older Adults with CKD: Two Sides of the Same Coin. Kidney & Blood Pressure Research. 49(1). 978–986.
6.
Piragine, Eugenia, et al.. (2023). Circulating Levels of Hydrogen Sulfide (H2S) in Patients with Age-Related Diseases: A Systematic Review and Meta-Analysis. Biomolecules. 13(7). 1023–1023. 24 indexed citations
7.
Convertino, Irma, Massimiliano Cazzato, Rosa Gini, et al.. (2023). Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy. Frontiers in Pharmacology. 14. 1244486–1244486.
8.
Lombardi, Niccolò, et al.. (2023). Adherence to riluzole therapy in patients with amyotrophic lateral sclerosis in three Italian regions—The CAESAR study. Pharmacoepidemiology and Drug Safety. 33(1). e5736–e5736. 1 indexed citations
9.
Convertino, Irma, Valentina Lorenzoni, Rosa Gini, et al.. (2023). Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis. Pharmaceuticals. 16(3). 465–465. 1 indexed citations
10.
Ciccone, Valerio, et al.. (2022). Safety of Anti-Angiogenic Drugs in Pediatric Patients with Solid Tumors: A Systematic Review and Meta-Analysis. Cancers. 14(21). 5315–5315. 11 indexed citations
11.
Virgili, Gianni, Mariacristina Parravano, Davide Petri, et al.. (2022). The Association between Vision Impairment and Depression: A Systematic Review of Population-Based Studies. Journal of Clinical Medicine. 11(9). 2412–2412. 30 indexed citations
12.
Crescioli, Giada, Sandra Donnini, Marina Ziche, et al.. (2022). Sex differences in the utilization of drugs for COVID‐19 treatment among elderly residents in a sample of Italian nursing homes. Pharmacoepidemiology and Drug Safety. 31(5). 489–494. 2 indexed citations
13.
Baglietto, Laura, Nicola de Bortoli, Marta Mosca, et al.. (2022). Use of Biological Drugs for Psoriasis: A Drug-Utilization Study Using Tuscan Administrative Databanks. International Journal of Environmental Research and Public Health. 19(11). 6799–6799. 2 indexed citations
14.
Convertino, Irma, Rosa Gini, Massimiliano Cazzato, et al.. (2021). Trajectories of Adherence to Biologic Disease-Modifying Anti-Rheumatic Drugs in Tuscan Administrative Databases: The Pathfinder Study. Journal of Clinical Medicine. 10(24). 5743–5743. 3 indexed citations
15.
Reibaldi, Michele, Matteo Fallico, Teresio Avitabile, et al.. (2021). Frequency of Intravitreal Anti-VEGF Injections and Risk of Death. Ophthalmology Retina. 6(5). 369–376. 24 indexed citations
16.
Focosi, Daniele, Angelo Genoni, Ersilia Lucenteforte, et al.. (2021). Previous Humoral Immunity to the Endemic Seasonal Alphacoronaviruses NL63 and 229E Is Associated with Worse Clinical Outcome in COVID-19 and Suggests Original Antigenic Sin. Life. 11(4). 298–298. 20 indexed citations
17.
Romano, Vito, Mohit Parekh, Gianni Virgili, et al.. (2021). Gender Matching Did Not Affect 2-year Rejection or Failure Rates Following DSAEK for Fuchs Endothelial Corneal Dystrophy. American Journal of Ophthalmology. 235. 204–210. 7 indexed citations
18.
Moscato, Giovanna, Paola Mazzetti, Ersilia Lucenteforte, et al.. (2021). Assessment of automated high-throughput serological assays for prediction of high-titer SARS-CoV-2 neutralizing antibody. SHILAP Revista de lepidopterología. 1(1-2). 100016–100016. 5 indexed citations
19.
Lenge, Matteo, Carla Marini, Antonio Napolitano, et al.. (2020). Quantitative MRI-Based Analysis Identifies Developmental Limbic Abnormalities in PCDH19 Encephalopathy. Cerebral Cortex. 30(11). 6039–6050. 12 indexed citations
20.
Azzari, Chiara, Daniele Serranti, Francesco Nieddu, et al.. (2019). Significant impact of pneumococcal conjugate vaccination on pediatric parapneumonic effusion: Italy 2006–2018. Vaccine. 37(20). 2704–2711. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026